BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 32194861)

  • 1. Dysregulations of Functional RNA Modifications in Cancer, Cancer Stemness and Cancer Therapeutics.
    Uddin MB; Wang Z; Yang C
    Theranostics; 2020; 10(7):3164-3189. PubMed ID: 32194861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epigenetic N6-methyladenosine modification of RNA and DNA regulates cancer.
    Liang Z; Kidwell RL; Deng H; Xie Q
    Cancer Biol Med; 2020 Feb; 17(1):9-19. PubMed ID: 32296573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Roles of METTL3 in cancer: mechanisms and therapeutic targeting.
    Zeng C; Huang W; Li Y; Weng H
    J Hematol Oncol; 2020 Aug; 13(1):117. PubMed ID: 32854717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circular RNAs in Cancer: emerging functions in hallmarks, stemness, resistance and roles as potential biomarkers.
    Su M; Xiao Y; Ma J; Tang Y; Tian B; Zhang Y; Li X; Wu Z; Yang D; Zhou Y; Wang H; Liao Q; Wang W
    Mol Cancer; 2019 Apr; 18(1):90. PubMed ID: 30999909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deciphering the molecular mechanisms of epitranscriptome regulation in cancer.
    Han SH; Choe J
    BMB Rep; 2021 Feb; 54(2):89-97. PubMed ID: 33298243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surmounting cancer drug resistance: New insights from the perspective of N
    Li B; Jiang J; Assaraf YG; Xiao H; Chen ZS; Huang C
    Drug Resist Updat; 2020 Dec; 53():100720. PubMed ID: 32892147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-coding RNAs Functioning in Colorectal Cancer Stem Cells.
    Fanale D; Barraco N; Listì A; Bazan V; Russo A
    Adv Exp Med Biol; 2016; 937():93-108. PubMed ID: 27573896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging role of RNA methyltransferase METTL3 in gastrointestinal cancer.
    Wang Q; Geng W; Guo H; Wang Z; Xu K; Chen C; Wang S
    J Hematol Oncol; 2020 May; 13(1):57. PubMed ID: 32429972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of m
    Nombela P; Miguel-López B; Blanco S
    Mol Cancer; 2021 Jan; 20(1):18. PubMed ID: 33461542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA modifications in hematopoietic malignancies: a new research frontier.
    Qing Y; Su R; Chen J
    Blood; 2021 Aug; 138(8):637-648. PubMed ID: 34157073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The emerging roles of N6-methyladenosine (m6A) deregulation in liver carcinogenesis.
    Chen M; Wong CM
    Mol Cancer; 2020 Feb; 19(1):44. PubMed ID: 32111216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physio-pathological effects of m6A modification and its potential contribution to melanoma.
    Liao Y; Han P; Zhang Y; Ni B
    Clin Transl Oncol; 2021 Nov; 23(11):2269-2279. PubMed ID: 34105069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA Modifications in Cancer Stem Cell Biology.
    Cerneckis J; Cui Q; Liu W; Shi Y
    Cancer Treat Res; 2023; 190():25-47. PubMed ID: 38112998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small molecules that regulate the N
    Harrahill NJ; Hadden MK
    Eur J Med Chem; 2024 Aug; 274():116526. PubMed ID: 38805939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RMVar: an updated database of functional variants involved in RNA modifications.
    Luo X; Li H; Liang J; Zhao Q; Xie Y; Ren J; Zuo Z
    Nucleic Acids Res; 2021 Jan; 49(D1):D1405-D1412. PubMed ID: 33021671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interplay between m6A RNA methylation and noncoding RNA in cancer.
    Ma S; Chen C; Ji X; Liu J; Zhou Q; Wang G; Yuan W; Kan Q; Sun Z
    J Hematol Oncol; 2019 Nov; 12(1):121. PubMed ID: 31757221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA Modifications and Epigenetics in Modulation of Lung Cancer and Pulmonary Diseases.
    Teng PC; Liang Y; Yarmishyn AA; Hsiao YJ; Lin TY; Lin TW; Teng YC; Yang YP; Wang ML; Chien CS; Luo YH; Chen YM; Hsu PK; Chiou SH; Chien Y
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. m6A RNA methylation and beyond - The epigenetic machinery and potential treatment options.
    Garbo S; Zwergel C; Battistelli C
    Drug Discov Today; 2021 Nov; 26(11):2559-2574. PubMed ID: 34126238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dual role of N6-methyladenosine modification of RNAs is involved in human cancers.
    He L; Li J; Wang X; Ying Y; Xie H; Yan H; Zheng X; Xie L
    J Cell Mol Med; 2018 Oct; 22(10):4630-4639. PubMed ID: 30039919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles and Regulation of Long Noncoding RNAs in Hepatocellular Carcinoma.
    Lim LJ; Wong SYS; Huang F; Lim S; Chong SS; Ooi LL; Kon OL; Lee CG
    Cancer Res; 2019 Oct; 79(20):5131-5139. PubMed ID: 31337653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.